Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Tuesday, January 28, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
admin
-
January 18, 2025
Latest Pharma-News
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
admin
-
January 18, 2025
Latest Pharma-News
FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US
admin
-
March 8, 2024
Latest Pharma-News
BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use
admin
-
April 14, 2020
0
Latest Pharma-News
AstraZeneca-Merck genetic disorder treatment wins FDA nod
admin
-
April 14, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization to Decontaminate Millions of N95 Respirators
admin
-
April 13, 2020
0
Latest Pharma-News
FDA Approves AstraZeneca’s First Therapy for Children with Debilitating and Disfiguring Rare Disease
admin
-
April 13, 2020
0
Latest Pharma-News
New Ebola case confirmed in the Democratic Republic of the Congo
admin
-
April 12, 2020
0
Latest Pharma-News
Tagrisso Phase III ADAURA trial will be unblinded early after overwhelming efficiency in the adjuvant treatment of the patients with EGFR-mutated lung cancer
admin
-
April 11, 2020
0
Latest Pharma-News
Coronavirus (COVID-19) Update: FDA Authorizes Blood Purification Device to Treat COVID-19
admin
-
April 11, 2020
0
Latest Pharma-News
COVID-19: Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries
admin
-
April 10, 2020
0
Latest Pharma-News
Pfizer clinches coronavirus vaccine deal, sees potential in antiviral treatment
admin
-
April 10, 2020
0
Latest Pharma-News
How AI will Affect the Healthcare-Jobs Published on October 13, 2019
admin
-
April 10, 2020
0
Latest Pharma-News
FDA Warns Seller of Fraudulent COVID-19 Products
admin
-
April 9, 2020
0
Latest Pharma-News
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combined with Limited Chemotherapy in First-Line Lung...
admin
-
April 9, 2020
0
1
...
123
124
125
...
145
Page 124 of 145
- Advertisment -
Most Read
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
January 24, 2025
First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease
January 18, 2025
Johnson & Johnson initiated submission of NDA application with U.S. FDA for TAR-200 for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
January 18, 2025